At a glance
- Originator Novartis
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Picornavirus infections
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Picornavirus infections in European Union (Unknown route)
- 28 Mar 1995 New profile
- 06 Mar 1995 Preclinical development for Picornavirus infections in European Union (Unknown route)